Target,Reference Ab,Method,HCDRs Designed,HCDR1,HCDR2,HCDR3,KD (nM),heavy,light,fitness
TNFRSF9,Utomilumab,Positive Control,,GYSFSTYW,IYPGDSYT,ARGYGIFDY,45.66385442285714,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,45.66385442285714
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,SRGSGIFDY,295.0000000000003,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCSRGSGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,295.0000000000003
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,TRGSGLFDY,225.0000000000001,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCTRGSGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,225.0000000000001
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,ARGWGVFDY,122.00000000000004,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGWGVFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,122.00000000000004
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,ARGVGIFDY,158.00000000000017,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGVGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,158.00000000000017
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,ARGIGIFDY,128.0000000000001,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGIGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,128.0000000000001
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,SRGYGVFDY,130.00000000000006,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCSRGYGVFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,130.00000000000006
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,ARGIGLFDY,175.0,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGIGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,175.0
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,ARGVGLFDY,152.99999999999986,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGVGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,152.99999999999986
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,ARGTGLFDY,95.6000000000001,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGTGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,95.6000000000001
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,TRGVGIFDY,92.30000000000008,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCTRGVGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,92.30000000000008
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,TRGYGVFDY,96.20000000000005,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCTRGYGVFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,96.20000000000005
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,TRGVGLFDY,140.99999999999991,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCTRGVGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,140.99999999999991
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,TRGTGLFDY,142.00000000000009,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCTRGTGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,142.00000000000009
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,ARGWGLFDY,60.29999999999998,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGWGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,60.29999999999998
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,ARGWGIFDY,45.00000000000003,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGWGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,45.00000000000003
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,ARGYGIFDY,45.66400000000005,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,45.66400000000005
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,SRGYGIFDY,39.70000000000001,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCSRGYGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,39.70000000000001
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,ARGIGVFDY,33.400000000000006,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGIGVFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,33.400000000000006
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,TRGTGIFDY,92.00000000000006,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCTRGTGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,92.00000000000006
TNFRSF9,Utomilumab,Inverse Folding,HCDR3,GYSFSTYW,IYPGDSYT,ARGHGVFDY,315.0000000000003,EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGHGVFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,315.0000000000003
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYTFSSYW,IYPGDSYT,TRGYGIFDY,95.39999999999992,EVQLVQSGAEVKKPGESLRISCKGSGYTFSSYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCTRGYGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,95.39999999999992
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYTFSSYW,IYPGDSYT,ARGYGLFDY,86.10000000000004,EVQLVQSGAEVKKPGESLRISCKGSGYTFSSYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,86.10000000000004
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYTFSSYW,IYPGDSYT,TRGYGLFDY,109.00000000000004,EVQLVQSGAEVKKPGESLRISCKGSGYTFSSYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCTRGYGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,109.00000000000004
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYTFSNYW,IYPGDSYT,ARGYGIFDY,86.39999999999998,EVQLVQSGAEVKKPGESLRISCKGSGYTFSNYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,86.39999999999998
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYTFSDYW,IYPGDSYT,ARGYGLFDY,84.1,EVQLVQSGAEVKKPGESLRISCKGSGYTFSDYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,84.1
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYTFSDYW,IYPGDSYT,ARGYGIFDY,120.00000000000009,EVQLVQSGAEVKKPGESLRISCKGSGYTFSDYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,120.00000000000009
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYSFSSYW,IYPGDSYT,ARGYGVFDY,228.00000000000009,EVQLVQSGAEVKKPGESLRISCKGSGYSFSSYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGVFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,228.00000000000009
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYSFSSYW,IYPGDSYT,ARGTGLFDY,150.00000000000003,EVQLVQSGAEVKKPGESLRISCKGSGYSFSSYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGTGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,150.00000000000003
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYTFSNYW,IYPGDSYT,ARGYGLFDY,116.9999999999999,EVQLVQSGAEVKKPGESLRISCKGSGYTFSNYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,116.9999999999999
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYTFSSYW,IYPGNSYT,ARGDGVFDY,32.89999999999998,EVQLVQSGAEVKKPGESLRISCKGSGYTFSSYWISWVRQMPGKGLEWMGKIYPGNSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGDGVFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,32.89999999999998
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYSFSNYW,IYPGDSYT,ARGYGLFDY,145.0000000000001,EVQLVQSGAEVKKPGESLRISCKGSGYSFSNYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,145.0000000000001
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYSFSSYW,IYPGDSYT,ARGYGLFDY,51.10000000000001,EVQLVQSGAEVKKPGESLRISCKGSGYSFSSYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,51.10000000000001
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYTFSSYW,IYPGDSYT,ARGYGILDY,59.4,EVQLVQSGAEVKKPGESLRISCKGSGYTFSSYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGILDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,59.4
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYTFSSYW,IYPGDSYT,ARGYGIFDY,58.59999999999996,EVQLVQSGAEVKKPGESLRISCKGSGYTFSSYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,58.59999999999996
TNFRSF9,Utomilumab,Inverse Folding,HCDR123,GYTFSNYW,IYPGDSYT,ARGEGLFDY,51.00000000000004,EVQLVQSGAEVKKPGESLRISCKGSGYTFSNYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGEGLFDYWGQGTLVTVSS,SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL,51.00000000000004
